# SV Health Investors: portfolio, investments and team

> SV Health Investors is a vc firm based in United Kingdom. 70 investments on record, 11 in the last 12 months, latest Oct 2026.

Source: https://millionrounds.com/fund/sv-health-investors (Millionrounds; every figure on the page links to its filing or article)

United Kingdom · [Investor](https://millionrounds.com/investors)

# SV Health Investors

Last cheque observed Oct 2026; 70 cheques on record.

Email

Deploying now VC firm

Venture Series A Series B Biotechnology Health Care

Follow SV Health Investors and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fsv-health-investors)

Deploying now

**73%** of best year **11** **cheques in 12 months**, 70 on record

Since the last cheque **16** days **00** hrs **00** min **00** sec

Median round **$34M** Rounds led **1 of 70** Sole investor **13 rounds** Exits **1 from the portfolio** Mostly in **United States, 59%**

Pitch SV Health Investors

Another investor of this name exists, and we could not establish from the rounds which of them the press meant. Treat the record below as possibly belonging to either. [Tell us which](https://millionrounds.com/corrections?slug=sv-health-investors) if you know.

## SV Health Investors highlights

- 01 11 cheques in the last 12 months
- 02 Mostly Venture and Series A: 65% of its rounds
- 03 Sole investor in 13 rounds, median $18M
- 04 1 exits from the portfolio

## What they do

- **Type:** VC firm (from a list, unverified)
- **Cheque size:** Not stated
- **Sectors:** Biotechnology Health Care
- **Based in:** United Kingdom
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **70 appearances**

- **2026** 10 rounds
- **Oct** **[OMass Therapeutics](https://millionrounds.com/company/omass-therapeutics)** Series C · GB · Jefferson Life Sciences **$310M** With 12 others
- **Jul** **[AdvanCell](https://millionrounds.com/company/advancell)** Series D · AU · QRM Capital **$315M** With 16 others
- **Jul** **[Alchemab Therapeutics](https://millionrounds.com/company/alchemab-therapeutics)** Series A · GB **$34M** With 4 others
- **Jul** **[Draig Therapeutics](https://millionrounds.com/company/draig-therapeutics)** Series B · GB · Jefferson Life Sciences **$65M** With 6 others
- **Jun** **[Harness Therapeutics](https://millionrounds.com/company/harness-therapeutics)** Venture · GB **Undisclosed** Sole investor
- **May** **[NinaMED](https://millionrounds.com/company/ninamed)** AU · SPRIM Global Investments **$14M** With 1 other
- **May** **[Cerevance](https://millionrounds.com/company/cerevance)** Series C · US **$20M** With 1 other
- **Mar** **[Transposon Therapeutics](https://millionrounds.com/company/transposon-therapeutics)** Grant · US **$22M** With 1 other
- **Mar** **[Mestag Therapeutics](https://millionrounds.com/company/mestag-therapeutics)** Venture · GB **$40M** With 3 others
- **Jan** **[TRex Bio](https://millionrounds.com/company/trex-bio)** Venture · US **$50M** With 3 others
- **2025** 14 rounds
- **Nov** **[Imbria Pharmaceuticals](https://millionrounds.com/company/imbria-pharmaceuticals)** Venture · US **Undisclosed** With 3 others
- **Oct** **[X4 Pharmaceuticals](https://millionrounds.com/company/x4-pharmaceuticals)** US **$155M** With 5 others
- **Oct** **[Miach Orthopaedics](https://millionrounds.com/company/miach-orthopaedics)** Debt · US **$7.5M** With 1 other
- **Sept** **[KalVista Pharmaceuticals](https://millionrounds.com/company/kalvista-pharmaceuticals)** Debt · US **$125M** With 4 others
- **Sept** **[Dualitas Therapeutics](https://millionrounds.com/company/dualitas-therapeutics)** Series A · US **$65M** With 4 others
- **Jun** **[Draig Therapeutics](https://millionrounds.com/company/draig-therapeutics)** Series A · GB **$140M** With 2 others
- **May** **[Therini Bio](https://millionrounds.com/company/therini-bio)** Series A · US **$39M** With 4 others
- **May** **[Bardy Diagnostics](https://millionrounds.com/company/bardy-diagnostics)** Venture · US **$11M** Sole investor
- **May** **[Alpheus Medical](https://millionrounds.com/company/alpheus-medical)** Series B · US **$52M** With 2 others
- **Apr** **[Imbria Pharmaceuticals](https://millionrounds.com/company/imbria-pharmaceuticals)** Series B · US **$59M** With 2 others
- **Apr** **[AdvanCell](https://millionrounds.com/company/advancell)** Grant · AU **$11M** With 1 other
- **Mar** **[Perfuze](https://millionrounds.com/company/perfuze)** Growth · IE · Seroba Life Sciences **$24M** *Led*
- **Feb** **[Ria Health](https://millionrounds.com/company/ria-health)** Series B · US **$6.5M** With 2 others
- **Jan** **[Harness Therapeutics](https://millionrounds.com/company/harness-therapeutics)** Venture · GB **Undisclosed** Sole investor
- **2024** 7 rounds
- **Nov** **[TRex Bio](https://millionrounds.com/company/trex-bio)** Series B · US · Avego Management **$84M** With 8 others
- **Oct** **[Enara Bio](https://millionrounds.com/company/enara-bio)** Series B · GB **$33M** With 2 others
- **Oct** **[Brixton Biosciences](https://millionrounds.com/company/brixton-biosciences)** Grant · US **$2.0M** With 1 other
- **Oct** **[LOQUS23 THERAPEUTICS](https://millionrounds.com/company/loqus23-therapeutics)** Series A · GB **$46M** With 2 others
- **Sept** **[CSA Medical](https://millionrounds.com/company/csa-medical)** Series D · US **$53M** Sole investor
- **Sept** **[Spectrawave](https://millionrounds.com/company/spectrawave)** Series B · US **$50M** With 2 others
- **Apr** **[Cerevance](https://millionrounds.com/company/cerevance)** Series B · US **$47M** With 3 others
- **2023** 4 rounds
- **Dec** **[U.S. Renal Care](https://millionrounds.com/company/u-s-renal-care)** Venture · US **$4.0M** With 1 other
- **Nov** **[Vittoria Biotherapeutics](https://millionrounds.com/company/vittoria-biotherapeutics)** US · Tellus BioVentures **$15M** With 7 others
- **Nov** **[Eyebiotech](https://millionrounds.com/company/eyebiotech)** Series A · US **$65M** With 4 others
- **Sept** **[Sitryx Therapeutics](https://millionrounds.com/company/sitryx-therapeutics)** Series A · GB **$39M** With 4 others
- **2022** 2 rounds
- **Dec** **[Pulmocide](https://millionrounds.com/company/pulmocide)** Series C · GB **$52M** With 3 others
- **Mar** **[Rondo Therapeutics](https://millionrounds.com/company/rondo-therapeutics)** Series A · US **$67M** With 2 others
- **2021** 2 rounds
- **Nov** **[Quell Therapeutics](https://millionrounds.com/company/quell-therapeutics)** Series B · GB · UCL Technology Fund **$156M** With 3 others
- **Oct** **[Zerigo Health](https://millionrounds.com/company/zerigo-health)** Series B · US **$43M** With 1 other
- **2020** 5 rounds
- **Nov** **[Caraway Therapeutics](https://millionrounds.com/company/caraway-therapeutics)** Venture **Undisclosed** With 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

We hold **3** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## Exits from the portfolio

Companies it backed that were later bought or listed **1 in all**

**[Convergence Pharmaceuticals](https://millionrounds.com/company/convergence-pharmaceuticals)** Bought by [Biogen Idec](https://millionrounds.com/fund/biogen-idec) **$675M** Jan 2015

An exit counts when it came after the firm's first round in the company. From historical deal records.

## The cheque

Venture Series A Series B

Median round joined **$34M** the round, not its cheque Alone, median **$18M**

Led 1 of 70 rounds **1%**

- **Sole investor:** 13 rounds
- **Last cheque:** Oct 2026
- **Exits:** 1 from the portfolio

Rounds by stage said on their site

- Venture *21*
- Series A *16*
- Series B *12*
- Series D *4*
- Series C *4*

Cheques by month Led Joined

Nov 2023 Oct 2026

Often in the room with

- [Eli Lilly](https://millionrounds.com/fund/eli-lilly) 7
- [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) 6
- [Bain Capital Life Sciences](https://millionrounds.com/fund/bain-capital-life-sciences) 5
- [Janus Henderson Investors](https://millionrounds.com/fund/janus-henderson-investors) 4
- [Novo Holdings](https://millionrounds.com/fund/novo-ventures) 4
- [SR One](https://millionrounds.com/fund/sr-one) 4

**Pitching SV Health Investors?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as SV Health Investors. A count of rooms they were both in, not a relationship either has claimed.

[**Eli Lilly** Corporate VC **7** rounds together](https://millionrounds.com/fund/eli-lilly)[**RA Capital Management** Private equity **6** rounds together](https://millionrounds.com/fund/ra-capital-management)[**Bain Capital Life Sciences** Private equity **5** rounds together](https://millionrounds.com/fund/bain-capital-life-sciences)[**Janus Henderson Investors** Private equity **4** rounds together](https://millionrounds.com/fund/janus-henderson-investors)[**Novo Holdings** VC firm **4** rounds together](https://millionrounds.com/fund/novo-ventures)[**SR One** Corporate VC **4** rounds together](https://millionrounds.com/fund/sr-one)[**SV Life Sciences** VC firm **4** rounds together](https://millionrounds.com/fund/sv-life-sciences)[**Alexandria Real Estate Equities** VC firm **3** rounds together](https://millionrounds.com/fund/alexandria)[**Alexandria Venture Investments** VC firm **3** rounds together](https://millionrounds.com/fund/alexandria-venture-investments)[**British Business Bank** Corporate VC **3** rounds together](https://millionrounds.com/fund/national-security-strategic-investment-fund)[**Canaan** VC firm **3** rounds together](https://millionrounds.com/fund/canaan-partners)[**Catalio Capital Management** VC firm **3** rounds together](https://millionrounds.com/fund/catalio-capital-management)

## Recently backed

The latest companies SV Health Investors put money into.

[**OMass Therapeutics** $310M · Oct 2026](https://millionrounds.com/company/omass-therapeutics)[**AdvanCell** $315M · Jul 2026](https://millionrounds.com/company/advancell)[**Draig Therapeutics** $65M · Jul 2026](https://millionrounds.com/company/draig-therapeutics)[**Harness Therapeutics** Jun 2026](https://millionrounds.com/company/harness-therapeutics)[**Cerevance** $20M · May 2026](https://millionrounds.com/company/cerevance)[**Mestag Therapeutics** $40M · Mar 2026](https://millionrounds.com/company/mestag-therapeutics)

## On podcasts

1 episode naming SV Health Investors in the title, and 1 more that mention it.

- [Money Maze Podcast](https://millionrounds.com/podcasts/money-maze) 22 Mar 2023 · 57 min Top 3 Episodes of 2022 - #1 Dame Kate Bingham (Managing Partner of SV Health Investors) With [Kate Bingham](https://millionrounds.com/person/kate-bingham-3) Mentions [SV Health Investors](https://millionrounds.com/fund/sv-health-investors)[Boris Johnson](https://millionrounds.com/person/boris-johnson) Apple PodcastsShow page

### Mentioned in

- [Money Maze Podcast](https://millionrounds.com/podcasts/money-maze) 17 Nov 2022 · 57 min Dame Kate Bingham on Healthcare VC, Biotech & Leading the UK's COVID-19 Vaccine Taskforce Apple PodcastsShow page

## Quick answers about SV Health Investors

### What does SV Health Investors invest in?

SV Health Investors invests most often at Venture and Series A (65% of the rounds on record), in sectors such as Biotechnology and Health Care.

### How active is SV Health Investors?

70 investments on record, 11 of them in the last 12 months, and it led 1. The most recent was in Oct 2026.

### What has SV Health Investors invested in recently?

Its most recent investments on record: OMass Therapeutics (Series C, Oct 2026), AdvanCell (Series D, Jul 2026) and Alchemab Therapeutics (Series A, Jul 2026).

### How big are SV Health Investors's cheques?

The median round it joins is $34M.

### Does SV Health Investors lead rounds?

Sometimes: it led 1 of its 70 investments on record (1%).

### Where does SV Health Investors invest?

Most of the companies it backs are in the United States (59%), the United Kingdom (31%) and Australia (8%).

### Is SV Health Investors investing now?

Yes: it is actively investing, with 11 investments in the last 12 months.

### Who does SV Health Investors invest alongside?

Most often Eli Lilly (7 rounds together), RA Capital Management (6 rounds together) and Bain Capital Life Sciences (5 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=sv-health-investors) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=sv-health-investors)